Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.

Ahmet Bilici,Mahmut Gumus,Hatice Odabas,Nurten Kandemir,Umut Demirci,Sener Cihan,Ibrahim Vedat Bayoglu,Bala Basak Oven Ustaalioglu,Turkan Ozturk,Esma Turkmen,Zuhat Urakci,Mehmet Metin Şeker,Yusuf Gunaydin,Fatih Selcukbiricik,Nedim Turan,Alper Sevinc

Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.

2016

Ahmet Bilici
Mahmut Gumus
Hatice Odabas
Nurten Kandemir
Umut Demirci
Sener Cihan
Ibrahim Vedat Bayoglu
Bala Basak Oven Ustaalioglu
Turkan Ozturk
Esma Turkmen
Zuhat Urakci
Mehmet Metin Şeker
Yusuf Gunaydin
Fatih Selcukbiricik
Nedim Turan
Alper Sevinc

e16051Background: Approximately 50-60% of nonseminomatous germ-cell tumors (NSGCT) present with clinical stage I (CS I). Initial active surveillance, adjuvant chemotherapy and retroperitoneal lymph...

Keywords:

Germ cell tumors
Adjuvant
Cancer research
Pathology
Medicine
Chemotherapy
testicular germ cell
adjuvant chemotherapy
Oncology
Internal medicine
Lymph

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations